Eva Dokoupilova Selected Research

Pain (Aches)

1/2022	Efficacy and safety of secukinumab in patients with spondyloarthritis and enthesitis at the Achilles tendon: results from a phase 3b trial.
12/2020	An international, multicentre, double-blind, randomized study (DISSCO): effect of diacerein vs celecoxib on symptoms in knee osteoarthritis.
1/2010	Evaluation of the efficacy and safety of terguride in patients with fibromyalgia syndrome: results of a twelve-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eva Dokoupilova Research Topics

Disease

9	Rheumatoid Arthritis 12/2019 - 06/2013
5	Psoriatic Arthritis 06/2021 - 01/2018
4	Infections 06/2021 - 06/2013
3	Pain (Aches) 01/2022 - 01/2010
3	Ankylosing Spondylitis 02/2020 - 12/2017
2	Knee Osteoarthritis 12/2020 - 01/2018
1	Enthesopathy 01/2022
1	Herpes Zoster 06/2021
1	Osteoarthritis 12/2020
1	Bone Resorption 01/2019
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2018
1	Neutropenia 12/2017
1	Candidiasis (Moniliasis) 12/2017
1	Arthralgia (Joint Pain) 09/2017
1	Osteoporosis 09/2017
1	Nasopharyngitis 09/2017
1	Postmenopausal Osteoporosis 09/2017
1	Nausea 01/2010
1	Pathologic Constriction (Stenosis) 01/2010
1	Fibromyalgia (Fibrositis) 01/2010

Drug/Important Bio-Agent (IBA)

8	secukinumabIBA 01/2022 - 06/2013
4	Biosimilar PharmaceuticalsIBA 01/2018 - 01/2017
3	Adalimumab (Humira)FDA Link 12/2019 - 01/2018
3	Methotrexate (Mexate)FDA LinkGeneric 12/2019 - 01/2017
3	Monoclonal AntibodiesIBA 01/2019 - 09/2017
2	upadacitinibIBA 06/2021 - 01/2021
2	Janus Kinase InhibitorsIBA 06/2021 - 01/2021
2	Tumor Necrosis Factor InhibitorsIBA 03/2021 - 01/2017
2	C-Reactive ProteinIBA 02/2020 - 12/2017
2	Infliximab (Remicade)FDA Link 01/2018 - 01/2017
1	ixekizumabIBA 03/2021
1	Celecoxib (Celebrex)FDA Link 12/2020
1	diacereinIBA 12/2020
1	FKB327IBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	BI 655064IBA 01/2019
1	AutoantibodiesIBA 01/2019
1	Immunoglobulin A (IgA)IBA 01/2019
1	Immunoglobulin M (IgM)IBA 01/2019
1	Immunoglobulins (Immunoglobulin)IBA 01/2019
1	LigandsIBA 01/2019
1	Rheumatoid FactorIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 01/2019
1	Prostaglandins AIBA 02/2018
1	Etanercept (Enbrel)FDA Link 02/2018
1	triamcinolone hexacetonide (Aristospan)FDA Link 01/2018
1	Hyaluronic Acid (Hyaluronan)IBA 01/2018
1	romosozumabIBA 09/2017
1	Teriparatide (Parathar)FDA Link 09/2017
1	Diphosphonates (Bisphosphonates)IBA 09/2017
1	Alendronate (Alendronate Sodium)FDA LinkGeneric 09/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2010
1	dironyl (terguride)IBA 01/2010

Therapy/Procedure

3	Therapeutics 01/2018 - 01/2017
1	Self Administration (Administration, Self) 01/2018
1	Intra-Articular Injections 01/2018